Our virus-like particles (VLP) vaccine is in Phase II stage

Our virus-like particles (VLP) vaccine is in Phase II stage
COVIBEL, the innovative local Corona Virus vaccine, which is on the vaccine candidate list of the World Health Organization, produced at the biotechnological pharmaceutical raw material facilities of Nobel İlaç in Gebze Marmara Teknokent, quality controls were completed and filled in the Nobel İlaç Düzce biotechnological drug filling facilities. We are very proud and happy to share with you that it has been approved for PHASE-II (clinical) studies.

Nobel, working 24 hours with TÜBİTAK, METU and Bilkent University, this project, which we realized as the best fruit of the strategic partnership of public, industry and academia, is 'Worthwhile For You'.

If you would like to volunteer to make an impact on the early completion of the study, you can contact Can Ünlüsoy from Nobel Pharmaceuticals Biotechnology Department (can.unlusoy@nobel.com.tr) or you can apply online at www.onkoloji.gov.tr and www.covid19.tubitak.gov.tr.

Because we know that 'Health is Worth It'.

The centers where the study will be carried out:

  • Ankara Onkoloji Eğitim ve Araştırma Hastanesi, Ankara
  • Kocaeli Üniversitesi Hastanesi, Kocaeli
  • Yedikule Göğüs Hastalıkları Hastanesi, İstanbul